BACKGROUND: Yellow fever (YF) is a hemorrhagic disease caused by an arbovirus endemic in South America, with recent outbreaks in the last years. Severe cases exhibit fulminant hepatitis, but there are no studies regarding its late-term effects on liver parenchyma. Thus, the aim of this study was to determine the frequency and grade of liver fibrosis in patients who recovered from severe YF and to point out potential predictors of this outcome. METHODOLOGY/PRINCIPAL FINDINGS: We followed-up 18 patients who survived severe YF during a recent outbreak (January-April 2018) in Brazil using ultrasound (US) with shear-wave elastography (SWE) at 6 months after symptoms onset. No patient had previous history of liver disease. Median liver stiffness (LS) was 5.3 (4.6-6.4) kPa. 2 (11.1%) patients were classified as Metavir F2, 1 (8.3%) as F3 and 1 (8.3%) as F4; these two last patients had features of cardiogenic liver congestion on Doppler analysis. Age and cardiac failure were associated with increased LS (p = 0.036 and p = 0.024, respectively). SAPS-3 at ICU admission showed a tendency of association with significant fibrosis (≥ F2; p = 0.053). 7 patients used sofosbuvir in a research protocol, of which none showed liver fibrosis (p = 0.119). CONCLUSIONS/SIGNIFICANCE: We found a low frequency of liver fibrosis in severe YF survivors. US with SWE may have a role in the follow up of patients of age and / or with comorbidities after hospital discharge in severe YF, a rare but reemergent disease.
BACKGROUND:Yellow fever (YF) is a hemorrhagic disease caused by an arbovirus endemic in South America, with recent outbreaks in the last years. Severe cases exhibit fulminant hepatitis, but there are no studies regarding its late-term effects on liver parenchyma. Thus, the aim of this study was to determine the frequency and grade of liver fibrosis in patients who recovered from severe YF and to point out potential predictors of this outcome. METHODOLOGY/PRINCIPAL FINDINGS: We followed-up 18 patients who survived severe YF during a recent outbreak (January-April 2018) in Brazil using ultrasound (US) with shear-wave elastography (SWE) at 6 months after symptoms onset. No patient had previous history of liver disease. Median liver stiffness (LS) was 5.3 (4.6-6.4) kPa. 2 (11.1%) patients were classified as Metavir F2, 1 (8.3%) as F3 and 1 (8.3%) as F4; these two last patients had features of cardiogenic liver congestion on Doppler analysis. Age and cardiac failure were associated with increased LS (p = 0.036 and p = 0.024, respectively). SAPS-3 at ICU admission showed a tendency of association with significant fibrosis (≥ F2; p = 0.053). 7 patients used sofosbuvir in a research protocol, of which none showed liver fibrosis (p = 0.119). CONCLUSIONS/SIGNIFICANCE: We found a low frequency of liver fibrosis in severe YF survivors. US with SWE may have a role in the follow up of patients of age and / or with comorbidities after hospital discharge in severe YF, a rare but reemergent disease.
Authors: Juarez A S Quaresma; Vera L R S Barros; Carla Pagliari; Elaine R Fernandes; Heitor F Andrade; Pedro F C Vasconcelos; Maria I S Duarte Journal: Trans R Soc Trop Med Hyg Date: 2006-07-26 Impact factor: 2.184
Authors: Christoph F Dietrich; Jeffrey Bamber; Annalisa Berzigotti; Simona Bota; Vito Cantisani; Laurent Castera; David Cosgrove; Giovanna Ferraioli; Mireen Friedrich-Rust; Odd Helge Gilja; Ruediger Stephan Goertz; Thomas Karlas; Robert de Knegt; Victor de Ledinghen; Fabio Piscaglia; Bogdan Procopet; Adrian Saftoiu; Paul S Sidhu; Ioan Sporea; Maja Thiele Journal: Ultraschall Med Date: 2017-04-13 Impact factor: 6.548
Authors: Luciana Casadio; Ana C Nastri; Fernanda M Malta; Jordana Araujo; Julia B Silva; Jorge Salomao; Juliana Yamashiro; Ana P Salles; Michele G Gouvea; Cristina Kanamura; Fabiana R Lima; Ryan Y Tanigawa; Evandro S Melo; Roque Lima; Débora Terrabuio; Eduardo Cançado; Yeh-Li Ho; Ester C Sabino; João R Pinho; Flair J Carrilho; Venancio A Alves; Anna S Levin Journal: N Engl J Med Date: 2020-05-21 Impact factor: 91.245
Authors: Yeon Seok Seo; Soon Ho Um; Sang-Jun Suh; Eun Suk Jung; Jin Su Jang; Yong Dae Kwon; Sang Hoon Park; Bora Keum; Yong Sik Kim; Yoon Tae Jeen; Hoon Jai Chun; Chang Duck Kim; Ho Sang Ryu Journal: Korean J Hepatol Date: 2008-12
Authors: Freya M Shearer; Catherine L Moyes; David M Pigott; Oliver J Brady; Fatima Marinho; Aniruddha Deshpande; Joshua Longbottom; Annie J Browne; Moritz U G Kraemer; Kathleen M O'Reilly; Joachim Hombach; Sergio Yactayo; Valdelaine E M de Araújo; Aglaêr A da Nóbrega; Jonathan F Mosser; Jeffrey D Stanaway; Stephen S Lim; Simon I Hay; Nick Golding; Robert C Reiner Journal: Lancet Infect Dis Date: 2017-08-16 Impact factor: 25.071